Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Intervalo de año de publicación
2.
PLoS One ; 18(4): e0284248, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37058544

RESUMEN

This study describes the incidence, evolution and prognosis of acute kidney injury (AKI) in critical COVID-19 during the first pandemic wave. We performed a prospective, observational, multicenter study of confirmed COVID-19 patients admitted to 19 intensive care units (ICUs) in Catalonia (Spain). Data regarding demographics, comorbidities, drug and medical treatment, physiological and laboratory results, AKI development, need for renal replacement therapy (RRT) and clinical outcomes were collected. Descriptive statistics and logistic regression analysis for AKI development and mortality were used. A total of 1,642 patients were enrolled (mean age 63 (15.95) years, 67.5% male). Mechanical ventilation (MV) was required for 80.8% and 64.4% of these patients, who were in prone position, while 67.7% received vasopressors. AKI at ICU admission was 28.4% and increased to 40.1% during ICU stay. A total of 172 (10.9%) patients required RRT, which represents 27.8% of the patients who developed AKI. AKI was more frequent in severe acute respiratory distress syndrome (ARDS) ARDS patients (68% vs 53.6%, p<0.001) and in MV patients (91.9% vs 77.7%, p<0.001), who required the prone position more frequently (74.8 vs 61%, p<0.001) and developed more infections. ICU and hospital mortality were increased in AKI patients (48.2% vs 17.7% and 51.1% vs 19%, p <0.001) respectively). AKI was an independent factor associated with mortality (IC 1.587-3.190). Mortality was higher in AKI patients who required RRT (55.8% vs 48.2%, p <0.04). Conclusions There is a high incidence of AKI in critically ill patients with COVID-19 disease and it is associated with higher mortality, increased organ failure, nosocomial infections and prolonged ICU stay.


Asunto(s)
Lesión Renal Aguda , COVID-19 , Humanos , Masculino , Persona de Mediana Edad , Femenino , España/epidemiología , COVID-19/complicaciones , COVID-19/epidemiología , Estudios Prospectivos , Enfermedad Crítica , Unidades de Cuidados Intensivos , Terapia de Reemplazo Renal , Lesión Renal Aguda/epidemiología , Lesión Renal Aguda/etiología , Lesión Renal Aguda/terapia , Estudios Retrospectivos , Factores de Riesgo
3.
Sci Prog ; 104(2): 368504211018580, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34078190

RESUMEN

Augmented renal clearance (ARC) is a phenomenon that can lead to a therapeutic failure of those drugs of renal clearance. The purpose of the study was to ascertain the prevalence of ARC in the critically ill patient, to study the glomerular filtration rate (GFR) throughout the follow-up and analyze the concordance between the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) estimation formula and measured GFR. Observational, prospective, multicenter study. ARC was defined as a creatinine clearance greater than 130 ml/min/1.73 m2. Eighteen hospitals were recruited. GFR measurements carried out twice weekly during a 2-month follow-up period. A total of 561 patients were included. ARC was found to have a non-negligible prevalence of 30%. More even, up to 10.7% already had ARC at intensive care unit (ICU) admission. No specific pattern of GFR was found during the follow-up. Patients in the ARC group were younger 56.5 (53.5-58.5) versus 66 (63.5-68.5) years than in the non-ARC group, p < 0.001. ICU mortality was lower in the ARC group, 6.9% versus 14.5%, p = 0.003. There was no concordance between the estimation of GFR by the CKD-EPI formula and GFR calculated from the 4-h urine. ARC is found in up to 30% of ICU patients, so renal removal drugs could be under dosed by up to 30%. And ARC is already detected on admission in 10%. It is a dynamic phenomenon without an established pattern that usually occurs in younger patients that can last for several weeks. And the CKD-EPI formula does not work to estimate the real creatinine clearance of these patients.


Asunto(s)
Insuficiencia Renal Crónica , Creatinina , Femenino , Tasa de Filtración Glomerular , Humanos , Pruebas de Función Renal , Masculino , Estudios Prospectivos
4.
Prog. obstet. ginecol. (Ed. impr.) ; 61(1): 12-15, ene.-feb. 2018. tab, ilus, graf
Artículo en Inglés | IBECS | ID: ibc-171496

RESUMEN

Knowing the number of obstetric complications is fundamental when auditing the activity of an obstetrics department. The Adverse Outcomes Index is a standardized measure that is easily calculated and could prove useful for evaluating potentially avoidable adverse events in the delivery room. We present the advantages and limitations of this index, which we have adopted in our department and consider an efficient tool in our setting (AU)


Conocer el número de complicaciones obstétricas es fundamental para auditar la actividad de un servicio de obstetricia. El índice de adversidad obstétrica es una medida estandarizada que puede ser fácilmente calculada y ser útil para valorar los eventos adversos potencialmente evitables en una sala de partos. Exponemos las ventajas y limitaciones de este índice que hemos adoptado en nuestra unidad y que valoramos como una herramienta eficiente en nuestro entorno (AU)


Asunto(s)
Humanos , Femenino , Complicaciones del Trabajo de Parto/epidemiología , Parto Obstétrico/efectos adversos , Seguridad del Paciente , Servicio de Ginecología y Obstetricia en Hospital/estadística & datos numéricos , Factores de Riesgo , Indicadores de Morbimortalidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA